Skip to main content Accessibility help
×
Home

The treatment of mixed states and the risk of switching to depression

  • Eduard Vieta (a1)

Abstract

There are few controlled studies evaluating the treatment of bipolar mixed states. Evidence suggests that mixed states may be more responsive to some anticonvulsants than to lithium. Olanzapine alone or in combination with divalproate or lithium has been adequately evaluated in randomized clinical trials involving mixed-state patients, whereas risperidone and quetiapine have not. There is also some evidence demonstrating the efficacy of ziprasidone and aripiprazole. The risk of switching to depression is high in mixed states. Conventional antipsychotics, such as haloperidol, may be less efficacious at protecting against a switch to depression than atypical antipsychotics, divalproate or lithium. When choosing drugs for the treatment of mania, and especially for the treatment of mixed states, their efficacy against manic and depressive symptoms, and their safety in terms of the risk of switching to depression should be taken into account.

Copyright

Corresponding author

E-mail address: evieta@clinic.ub.es (E. Vieta).

References

Hide All
[1]Bowden, CL, Calabrese, JR, Sachs, G, Yatham, LN, Asghar, SA, Hompland, Met al.A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Gen. Psychiatry 2003; 60:392400.
[2]Calabrese, JR, Keck, PE, Macfadden, W, Minkwitz, M, Ketter, TA, Weisler, RHet al.A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am. J. Psychiatry 2005 [in press]
[3]Ciapparelli, A, Dell’Osso, L, Tundo, A, Pini, S, Chiavacci, MC, Di Sacco, Iet al.Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. J. Clin. Psychiatry 2001; 62:552555.
[4]Colom, F, Vieta, E, Martinez-Aran, A, Reinares, M, Goikolea, JM, Benabarre, Aet al.A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch. Gen. Psychiatry 2003; 60:402407.
[5]Gyulai, L, Bowden, CL, McElroy, SL, Calabrese, JR, Petty, F, Swann, ACet al.Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology 2003; 28:13741382.
[6]Hirschfeld, RM, Keck, PE Jr., Kramer, M, Karcher, K, Canuso, C, Eerdekens, Met al.Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Am. J. Psychiatry 2004; 161:10571065.
[7]Hirschfeld, RM, Williams, JB, Spitzer, RL, Calabrese, JR, Flynn, L, Keck, PE Jr.et al.Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am. J. Psychiatry 2000; 157:18731875.
[8]Keller, MB, Lavori, PW, Coryell, W, Andreasen, NC, Endicott, J, Clayton, PJet al.Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. J. Am. Med. Assoc. 1986; 255:31383142.
[9]Khanna, S, Vieta, E, Lyons, B, Grossman, F, Eerdekens, M, Kramer, MRisperidone in the treatment of acute bipolar mania: a double-blind, placebo-controlled study of 290 patients. Br. J. Psychiatry 2005 [in press]
[10]Kupfer, DJ, Frank, E, Grochocinski, , Mallinger, AGStabilization in the treatment of mania, depression and mixed states. Acta Neuropsychiatr. 2000; 12:110114.
[11]Swann, AC, Bowden, CL, Morris, D, Calabrese, JR, Petty, F, Small, Jet al.Depression during mania. Treatment response to lithium or divalproex. Arch. Gen. Psychiatry 1997; 54:3742.
[12]Tohen, MF, Greil, W, Calabrese, JR, Sachs, GS, Yatham, LN, Müller-Oerlinghausen, et al. Olanzapine versus lithium in relapse/recurrence prevention in bipolar disorder: a randomized double-blind controlled 12–month clinical trial. Am J Psychiatry (in press).
[13]Tohen, M, Baker, RW, Altshuler, LL, Zarate, CA, Suppes, T, Ketter, TAet al.Olanzapine versus divalproex in the treatment of acute mania. Am. J. Psychiatry 2002; 159:10111017.
[14]Tohen, M, Chengappa, KN, Suppes, T, Baker, RW, Zarate, CA, Bowden, CLet al.Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser vs. mood stabiliser alone. Br. J. Psychiatry 2004; 184:337345.
[15]Tohen, M, Chengappa, KN, Suppes, T, Zarate, CA Jr., Calabrese, JR, Bowden, CLet al.Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch. Gen. Psychiatry 2002; 59:6269.
[16]Tohen, M, Goldberg, JF, Gonzalez-Pinto Arrillaga, AM, Azorin, JM, Vieta, E, Hardy-Bayle, MCet al.A 12-week, double-blind comparison of olanzapine vs. haloperidol in the treatment of acute mania. Arch. Gen. Psychiatry 2003; 60:12181226.
[17]Tohen, M, Jacobs, TG, Grundy, SL, McElroy, SL, Banov, MC, Janicak, PGet al.Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch. Gen. Psychiatry 2000; 57:841849.
[18]Tohen, M, Sanger, TM, McElroy, SL, Tollefson, GD, Chengappa, KN, Daniel, DGet al.Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am. J. Psychiatry 1999; 156:702709.
[19]Vieta, EBipolar mixed states and their treatment. Exp. Rev. Neurother. 2005; 5:6368.
[20]Vieta, E, Colom, FPsychological interventions in bipolar disorder: from wishful thinking to an evidence-based approach. Acta Psychiatr. Scand. 110Suppl 4222004 110.
[21]Vieta, E, Goikolea, JM, Corbella, B, Benabarre, A, Reinares, M, Martinez, Get al.Group for the Study of Risperidone in Affective Disorders (GSRAD). Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. J. Clin. Psychiatry 2001; 62:818825.

Keywords

The treatment of mixed states and the risk of switching to depression

  • Eduard Vieta (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

The treatment of mixed states and the risk of switching to depression

  • Eduard Vieta (a1)
Submit a response

Comments

No Comments have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *